Rank | Gene Set | Z-score |
---|---|---|
1 | surfactant homeostasis (GO:0043129) | 4.79681980 |
2 | brown fat cell differentiation (GO:0050873) | 4.54079515 |
3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.48878528 |
4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.48878528 |
5 | negative regulation of phagocytosis (GO:0050765) | 4.40036241 |
6 | regulation of sequestering of triglyceride (GO:0010889) | 4.12585058 |
7 | white fat cell differentiation (GO:0050872) | 4.11414081 |
8 | low-density lipoprotein particle clearance (GO:0034383) | 3.88851653 |
9 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.87770774 |
10 | regulation of growth of symbiont in host (GO:0044126) | 3.87770774 |
11 | negative regulation of growth of symbiont in host (GO:0044130) | 3.87770774 |
12 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.87770774 |
13 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.82991596 |
14 | negative regulation of interleukin-12 production (GO:0032695) | 3.82341425 |
15 | ribosomal small subunit assembly (GO:0000028) | 3.75223778 |
16 | response to peptidoglycan (GO:0032494) | 3.73237103 |
17 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.67676255 |
18 | cellular response to zinc ion (GO:0071294) | 3.64623386 |
19 | tolerance induction (GO:0002507) | 3.62895567 |
20 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.54329999 |
21 | phagocytosis, recognition (GO:0006910) | 3.50436944 |
22 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.50196866 |
23 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.48509878 |
24 | lipid storage (GO:0019915) | 3.48049169 |
25 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.37898665 |
26 | chemical homeostasis within a tissue (GO:0048875) | 3.33032988 |
27 | response to muramyl dipeptide (GO:0032495) | 3.31047769 |
28 | negative regulation of lipid storage (GO:0010888) | 3.29730622 |
29 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.26889939 |
30 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 3.26714227 |
31 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.25224358 |
32 | negative regulation of cell killing (GO:0031342) | 3.25171210 |
33 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.25171210 |
34 | neutrophil mediated immunity (GO:0002446) | 3.24928536 |
35 | myeloid dendritic cell differentiation (GO:0043011) | 3.24550834 |
36 | glycosphingolipid catabolic process (GO:0046479) | 3.23123565 |
37 | regulation of cholesterol storage (GO:0010885) | 3.20471535 |
38 | oligosaccharide catabolic process (GO:0009313) | 3.20060652 |
39 | granulocyte activation (GO:0036230) | 3.14716712 |
40 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.14379617 |
41 | negative regulation of stress fiber assembly (GO:0051497) | 3.11527812 |
42 | regulation of chemokine biosynthetic process (GO:0045073) | 3.10490156 |
43 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.10101230 |
44 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.08604146 |
45 | lymph vessel development (GO:0001945) | 3.08071370 |
46 | blood vessel maturation (GO:0001955) | 3.06608320 |
47 | regulation of mononuclear cell migration (GO:0071675) | 3.04567846 |
48 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.03916015 |
49 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.03916015 |
50 | viral transcription (GO:0019083) | 3.03114038 |
51 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.02186157 |
52 | myeloid dendritic cell activation (GO:0001773) | 2.98559278 |
53 | positive thymic T cell selection (GO:0045059) | 2.96925279 |
54 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.96133169 |
55 | valine metabolic process (GO:0006573) | 2.95457458 |
56 | angiogenesis involved in wound healing (GO:0060055) | 2.95411226 |
57 | regulation of T cell tolerance induction (GO:0002664) | 2.94663482 |
58 | endothelium development (GO:0003158) | 2.93828749 |
59 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.92997859 |
60 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.88493016 |
61 | positive regulation of mast cell activation (GO:0033005) | 2.86808434 |
62 | glycolipid catabolic process (GO:0019377) | 2.86757956 |
63 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.86298374 |
64 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 2.85329175 |
65 | regulation of vasculogenesis (GO:2001212) | 2.84837203 |
66 | heme biosynthetic process (GO:0006783) | 2.84218803 |
67 | regulation of mast cell degranulation (GO:0043304) | 2.83564980 |
68 | regulation of tolerance induction (GO:0002643) | 2.83392691 |
69 | translational termination (GO:0006415) | 2.82483451 |
70 | germinal center formation (GO:0002467) | 2.81956032 |
71 | immunoglobulin mediated immune response (GO:0016064) | 2.80389181 |
72 | regulation of monocyte differentiation (GO:0045655) | 2.79682045 |
73 | macrophage activation (GO:0042116) | 2.78571800 |
74 | cotranslational protein targeting to membrane (GO:0006613) | 2.78188063 |
75 | protein targeting to ER (GO:0045047) | 2.77645701 |
76 | signal peptide processing (GO:0006465) | 2.76796554 |
77 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.76523853 |
78 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.76235411 |
79 | myeloid leukocyte mediated immunity (GO:0002444) | 2.75817608 |
80 | endothelial cell morphogenesis (GO:0001886) | 2.75721314 |
81 | neutrophil activation (GO:0042119) | 2.74379345 |
82 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.73962543 |
83 | response to thyroid hormone (GO:0097066) | 2.72859200 |
84 | T cell migration (GO:0072678) | 2.72147798 |
85 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.71830136 |
86 | regulation of endothelial cell differentiation (GO:0045601) | 2.71102459 |
87 | macrophage activation involved in immune response (GO:0002281) | 2.70854348 |
88 | amino sugar catabolic process (GO:0046348) | 2.70852593 |
89 | morphogenesis of an endothelium (GO:0003159) | 2.70413429 |
90 | endothelial tube morphogenesis (GO:0061154) | 2.70413429 |
91 | hydrogen peroxide catabolic process (GO:0042744) | 2.69897841 |
92 | regulation of leukocyte degranulation (GO:0043300) | 2.69337801 |
93 | macrophage chemotaxis (GO:0048246) | 2.68059748 |
94 | transcytosis (GO:0045056) | 2.65292668 |
95 | regulation of chronic inflammatory response (GO:0002676) | 2.64888981 |
96 | myeloid cell activation involved in immune response (GO:0002275) | 2.63710517 |
97 | regulation of macrophage chemotaxis (GO:0010758) | 2.63581856 |
98 | positive regulation of mast cell degranulation (GO:0043306) | 2.61948627 |
99 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.61948627 |
100 | chondroitin sulfate biosynthetic process (GO:0030206) | 2.61865733 |
101 | positive regulation of B cell differentiation (GO:0045579) | 2.61736751 |
102 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.59645122 |
103 | protein localization to endoplasmic reticulum (GO:0070972) | 2.59540618 |
104 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.58940666 |
105 | ovulation from ovarian follicle (GO:0001542) | 2.58652767 |
106 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.58595152 |
107 | regulation of lymphocyte chemotaxis (GO:1901623) | 2.58127762 |
108 | microglial cell activation (GO:0001774) | 2.58037848 |
109 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.57887337 |
110 | myeloid leukocyte activation (GO:0002274) | 2.57799391 |
111 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.57695314 |
112 | monocyte chemotaxis (GO:0002548) | 2.57554481 |
113 | definitive hemopoiesis (GO:0060216) | 2.57028890 |
114 | ribosomal small subunit biogenesis (GO:0042274) | 2.56376796 |
115 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.56317787 |
116 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.55961919 |
117 | positive regulation of tolerance induction (GO:0002645) | 2.55742462 |
118 | NIK/NF-kappaB signaling (GO:0038061) | 2.55372055 |
119 | response to fungus (GO:0009620) | 2.55306426 |
120 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.54953769 |
121 | defense response to fungus (GO:0050832) | 2.54536190 |
122 | cellular response to interferon-beta (GO:0035458) | 2.54474068 |
123 | pentose-phosphate shunt (GO:0006098) | 2.54230040 |
124 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.54178741 |
125 | cellular extravasation (GO:0045123) | 2.54102039 |
126 | regulation of mast cell activation (GO:0033003) | 2.53913746 |
127 | peptide catabolic process (GO:0043171) | 2.53829742 |
128 | positive T cell selection (GO:0043368) | 2.53429428 |
129 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.53175051 |
130 | positive regulation of p38MAPK cascade (GO:1900745) | 2.53146329 |
131 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.51841600 |
132 | positive regulation of Rap GTPase activity (GO:0032854) | 2.51835324 |
133 | ceramide catabolic process (GO:0046514) | 2.50852125 |
134 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.50110021 |
135 | dendritic cell differentiation (GO:0097028) | 2.49922721 |
136 | negative regulation of interleukin-6 production (GO:0032715) | 2.49199977 |
137 | NADPH regeneration (GO:0006740) | 2.45338596 |
138 | endothelial cell differentiation (GO:0045446) | 2.44455570 |
139 | response to laminar fluid shear stress (GO:0034616) | 2.44352876 |
140 | negative regulation of granulocyte differentiation (GO:0030853) | 2.43998115 |
141 | leukocyte mediated cytotoxicity (GO:0001909) | 2.43638521 |
142 | lymphocyte chemotaxis (GO:0048247) | 2.43141669 |
143 | positive regulation of glomerulus development (GO:0090193) | 2.42965374 |
144 | secretory granule organization (GO:0033363) | 2.42937504 |
145 | cGMP-mediated signaling (GO:0019934) | 2.42852504 |
146 | response to protozoan (GO:0001562) | 2.42182830 |
147 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.40693075 |
148 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.40638266 |
149 | defense response to protozoan (GO:0042832) | 2.40174487 |
150 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.40063410 |
151 | regulation of response to interferon-gamma (GO:0060330) | 2.39938455 |
152 | neutrophil activation involved in immune response (GO:0002283) | 2.39526966 |
153 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.38974977 |
154 | dermatan sulfate metabolic process (GO:0030205) | 2.37892492 |
155 | mannose metabolic process (GO:0006013) | 2.37872593 |
156 | regulation of gamma-delta T cell activation (GO:0046643) | 2.37811747 |
157 | cellular response to arsenic-containing substance (GO:0071243) | 2.37465527 |
158 | negative thymic T cell selection (GO:0045060) | 2.37198086 |
159 | positive regulation of leukocyte degranulation (GO:0043302) | 2.37111677 |
160 | positive regulation of macrophage differentiation (GO:0045651) | 2.36905939 |
161 | T cell selection (GO:0045058) | 2.36630305 |
162 | positive regulation of smooth muscle cell proliferation (GO:0048661) | 2.36506724 |
163 | leukocyte aggregation (GO:0070486) | 2.36315143 |
164 | positive regulation of astrocyte differentiation (GO:0048711) | 2.35778251 |
165 | regulation of lymphocyte migration (GO:2000401) | 2.35683756 |
166 | neutrophil chemotaxis (GO:0030593) | 2.35644152 |
167 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.35352631 |
168 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.35246625 |
169 | negative regulation of interleukin-8 production (GO:0032717) | 2.35193101 |
170 | endothelial cell chemotaxis (GO:0035767) | 2.34567117 |
171 | translational elongation (GO:0006414) | 2.33206693 |
172 | negative regulation of protein autophosphorylation (GO:0031953) | 2.33158982 |
173 | positive regulation of lipid storage (GO:0010884) | 2.33124738 |
174 | keratan sulfate catabolic process (GO:0042340) | 2.32321796 |
175 | gas transport (GO:0015669) | 2.32269397 |
176 | lipid particle organization (GO:0034389) | 2.32101825 |
177 | establishment of endothelial barrier (GO:0061028) | 2.31376098 |
178 | trabecula morphogenesis (GO:0061383) | 2.30129162 |
179 | regulation of lipid storage (GO:0010883) | 2.29265072 |
180 | serine transport (GO:0032329) | 2.29238081 |
181 | mast cell activation (GO:0045576) | 2.29217413 |
182 | positive regulation of cholesterol efflux (GO:0010875) | 2.28875981 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.43788801 |
2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.50951863 |
3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.90201641 |
4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.79950482 |
5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.63961810 |
6 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.59654424 |
7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.43422318 |
8 | GATA1_22025678_ChIP-Seq_K562_Human | 3.28822134 |
9 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.90023924 |
10 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.88891023 |
11 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.84271192 |
12 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.77730707 |
13 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.61507391 |
14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.60647306 |
15 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.57663443 |
16 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.55818463 |
17 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.37973969 |
18 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.37375882 |
19 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.16699950 |
20 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.13996768 |
21 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.11129572 |
22 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.08820476 |
23 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.02917612 |
24 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.01838729 |
25 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.92893133 |
26 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.90486081 |
27 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.88061691 |
28 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.86286873 |
29 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.85542036 |
30 | MAF_26560356_Chip-Seq_TH1_Human | 1.82340675 |
31 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.82290895 |
32 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.80831190 |
33 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.74393071 |
34 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.73868385 |
35 | MYB_26560356_Chip-Seq_TH2_Human | 1.71573689 |
36 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.70287166 |
37 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.70215258 |
38 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.69430144 |
39 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.69264995 |
40 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.67992495 |
41 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.67930777 |
42 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67136536 |
43 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.64404950 |
44 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.63234518 |
45 | GATA1_19941826_ChIP-Seq_K562_Human | 1.62211920 |
46 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.60864780 |
47 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.59331338 |
48 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.56702371 |
49 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.54324631 |
50 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.54134867 |
51 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.52200905 |
52 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.52178057 |
53 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.51361204 |
54 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.47726902 |
55 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.47664869 |
56 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.42831804 |
57 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.42813032 |
58 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.41602765 |
59 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.39556677 |
60 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.39456468 |
61 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.38696937 |
62 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.38489859 |
63 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.37750309 |
64 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.36742595 |
65 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.35123409 |
66 | MYB_26560356_Chip-Seq_TH1_Human | 1.34315345 |
67 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.34053407 |
68 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.29829119 |
69 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.28643952 |
70 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.23235021 |
71 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.21899345 |
72 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21276050 |
73 | GATA2_19941826_ChIP-Seq_K562_Human | 1.21198398 |
74 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.21063749 |
75 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21022618 |
76 | UTX_26944678_Chip-Seq_JUKART_Human | 1.18181370 |
77 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.17971712 |
78 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.17960575 |
79 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.17844946 |
80 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.17658362 |
81 | CJUN_26792858_Chip-Seq_BT549_Human | 1.17000668 |
82 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.16264368 |
83 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16124213 |
84 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.15789492 |
85 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.15658807 |
86 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.15626532 |
87 | KDM2B_26808549_Chip-Seq_K562_Human | 1.14097986 |
88 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.14095320 |
89 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13709771 |
90 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13032658 |
91 | MAF_26560356_Chip-Seq_TH2_Human | 1.12974422 |
92 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10120861 |
93 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.09904465 |
94 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.08566734 |
95 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.08566734 |
96 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.07844626 |
97 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07550851 |
98 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07326720 |
99 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06257536 |
100 | MYC_22102868_ChIP-Seq_BL_Human | 1.05812995 |
101 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05183223 |
102 | SPI1_23127762_ChIP-Seq_K562_Human | 1.03359765 |
103 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.02050049 |
104 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.98289117 |
105 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.98257389 |
106 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.98257389 |
107 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97119174 |
108 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97061565 |
109 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95977061 |
110 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.95423995 |
111 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92739118 |
112 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.92657632 |
113 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.91948107 |
114 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91091495 |
115 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.91079989 |
116 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.90810323 |
117 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.90318054 |
118 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.90072147 |
119 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.89995086 |
120 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.89167767 |
121 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.88902437 |
122 | GATA3_26560356_Chip-Seq_TH2_Human | 0.86718745 |
123 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.83423092 |
124 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.82811792 |
125 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.81493281 |
126 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.80832069 |
127 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.80454899 |
128 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.77644326 |
129 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.76417467 |
130 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.75630728 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003724_increased_susceptibility_to | 4.83709937 |
2 | MP0005670_abnormal_white_adipose | 3.55511227 |
3 | MP0005058_abnormal_lysosome_morphology | 3.11913468 |
4 | MP0001853_heart_inflammation | 3.02337922 |
5 | MP0009840_abnormal_foam_cell | 2.86467392 |
6 | MP0001879_abnormal_lymphatic_vessel | 2.76328998 |
7 | MP0006082_CNS_inflammation | 2.73386618 |
8 | MP0003172_abnormal_lysosome_physiology | 2.69502072 |
9 | MP0000604_amyloidosis | 2.48062530 |
10 | MP0004147_increased_porphyrin_level | 2.36315063 |
11 | MP0000343_altered_response_to | 2.18443424 |
12 | MP0004782_abnormal_surfactant_physiolog | 2.12702943 |
13 | MP0003436_decreased_susceptibility_to | 2.12402593 |
14 | MP0003828_pulmonary_edema | 2.11965249 |
15 | MP0005666_abnormal_adipose_tissue | 2.08606213 |
16 | MP0004185_abnormal_adipocyte_glucose | 2.01841267 |
17 | MP0001958_emphysema | 1.97347062 |
18 | MP0000685_abnormal_immune_system | 1.96384416 |
19 | MP0002166_altered_tumor_susceptibility | 1.94230372 |
20 | MP0009785_altered_susceptibility_to | 1.93648146 |
21 | MP0001533_abnormal_skeleton_physiology | 1.92606389 |
22 | MP0003303_peritoneal_inflammation | 1.92168367 |
23 | MP0005164_abnormal_response_to | 1.85680939 |
24 | MP0004510_myositis | 1.84749099 |
25 | MP0004130_abnormal_muscle_cell | 1.84215182 |
26 | MP0009333_abnormal_splenocyte_physiolog | 1.83076918 |
27 | MP0004947_skin_inflammation | 1.82729191 |
28 | MP0001835_abnormal_antigen_presentation | 1.77099589 |
29 | MP0006054_spinal_hemorrhage | 1.74788499 |
30 | MP0003329_amyloid_beta_deposits | 1.71321305 |
31 | MP0001545_abnormal_hematopoietic_system | 1.67427344 |
32 | MP0005397_hematopoietic_system_phenotyp | 1.67427344 |
33 | MP0002419_abnormal_innate_immunity | 1.67285574 |
34 | MP0002933_joint_inflammation | 1.65957108 |
35 | MP0003763_abnormal_thymus_physiology | 1.63070385 |
36 | MP0003191_abnormal_cellular_cholesterol | 1.62849953 |
37 | MP0003186_abnormal_redox_activity | 1.60916265 |
38 | MP0002148_abnormal_hypersensitivity_rea | 1.60524488 |
39 | MP0002405_respiratory_system_inflammati | 1.59352193 |
40 | MP0000920_abnormal_myelination | 1.55091365 |
41 | MP0005167_abnormal_blood-brain_barrier | 1.52660383 |
42 | MP0005000_abnormal_immune_tolerance | 1.52081386 |
43 | MP0004272_abnormal_basement_membrane | 1.50768939 |
44 | MP0002006_tumorigenesis | 1.49258535 |
45 | MP0005025_abnormal_response_to | 1.45773969 |
46 | MP0003646_muscle_fatigue | 1.43943899 |
47 | MP0003656_abnormal_erythrocyte_physiolo | 1.43725410 |
48 | MP0001790_abnormal_immune_system | 1.38661457 |
49 | MP0005387_immune_system_phenotype | 1.38661457 |
50 | MP0005451_abnormal_body_composition | 1.38300941 |
51 | MP0005671_abnormal_response_to | 1.36855446 |
52 | MP0005375_adipose_tissue_phenotype | 1.36251033 |
53 | MP0003279_aneurysm | 1.34909591 |
54 | MP0005166_decreased_susceptibility_to | 1.32517557 |
55 | MP0000465_gastrointestinal_hemorrhage | 1.31998668 |
56 | MP0010368_abnormal_lymphatic_system | 1.31933913 |
57 | MP0005310_abnormal_salivary_gland | 1.31391398 |
58 | MP0005165_increased_susceptibility_to | 1.29910878 |
59 | MP0002420_abnormal_adaptive_immunity | 1.29802566 |
60 | MP0009384_cardiac_valve_regurgitation | 1.28999796 |
61 | MP0001819_abnormal_immune_cell | 1.28539186 |
62 | MP0008438_abnormal_cutaneous_collagen | 1.27636159 |
63 | MP0002254_reproductive_system_inflammat | 1.26745172 |
64 | MP0009379_abnormal_foot_pigmentation | 1.26346266 |
65 | MP0004883_abnormal_blood_vessel | 1.26287625 |
66 | MP0003448_altered_tumor_morphology | 1.25764081 |
67 | MP0000858_altered_metastatic_potential | 1.25588361 |
68 | MP0002139_abnormal_hepatobiliary_system | 1.24939880 |
69 | MP0009278_abnormal_bone_marrow | 1.24752180 |
70 | MP0002452_abnormal_antigen_presenting | 1.24431380 |
71 | MP0002971_abnormal_brown_adipose | 1.23524549 |
72 | MP0009115_abnormal_fat_cell | 1.22121706 |
73 | MP0002723_abnormal_immune_serum | 1.19706908 |
74 | MP0000383_abnormal_hair_follicle | 1.19645265 |
75 | MP0008469_abnormal_protein_level | 1.19387270 |
76 | MP0001851_eye_inflammation | 1.18740286 |
77 | MP0000249_abnormal_blood_vessel | 1.17820666 |
78 | MP0000013_abnormal_adipose_tissue | 1.16780900 |
79 | MP0008004_abnormal_stomach_pH | 1.15362953 |
80 | MP0005390_skeleton_phenotype | 1.13847943 |
81 | MP0006138_congestive_heart_failure | 1.13265183 |
82 | MP0010155_abnormal_intestine_physiology | 1.10271958 |
83 | MP0002998_abnormal_bone_remodeling | 1.10218530 |
84 | MP0001800_abnormal_humoral_immune | 1.10159899 |
85 | MP0003453_abnormal_keratinocyte_physiol | 1.09585825 |
86 | MP0001881_abnormal_mammary_gland | 1.08843574 |
87 | MP0002396_abnormal_hematopoietic_system | 1.07250837 |
88 | MP0003950_abnormal_plasma_membrane | 1.06948888 |
89 | MP0001542_abnormal_bone_strength | 1.06557376 |
90 | MP0001501_abnormal_sleep_pattern | 1.04798262 |
91 | MP0003075_altered_response_to | 1.04453320 |
92 | MP0009764_decreased_sensitivity_to | 1.01823424 |
93 | MP0008995_early_reproductive_senescence | 0.99525005 |
94 | MP0005595_abnormal_vascular_smooth | 0.99403282 |
95 | MP0001845_abnormal_inflammatory_respons | 0.98998121 |
96 | MP0002398_abnormal_bone_marrow | 0.98187468 |
97 | MP0003091_abnormal_cell_migration | 0.97495953 |
98 | MP0003011_delayed_dark_adaptation | 0.97318627 |
99 | MP0002132_abnormal_respiratory_system | 0.94378471 |
100 | MP0000716_abnormal_immune_system | 0.91980214 |
101 | MP0002133_abnormal_respiratory_system | 0.90948080 |
102 | MP0005388_respiratory_system_phenotype | 0.90948080 |
103 | MP0002722_abnormal_immune_system | 0.90254735 |
104 | MP0005464_abnormal_platelet_physiology | 0.90052570 |
105 | MP0005385_cardiovascular_system_phenoty | 0.89564465 |
106 | MP0001544_abnormal_cardiovascular_syste | 0.89564465 |
107 | MP0001663_abnormal_digestive_system | 0.88033441 |
108 | MP0003566_abnormal_cell_adhesion | 0.87310923 |
109 | MP0004484_altered_response_of | 0.87141318 |
110 | MP0008260_abnormal_autophagy | 0.87011526 |
111 | MP0000767_abnormal_smooth_muscle | 0.86596367 |
112 | MP0002009_preneoplasia | 0.86492588 |
113 | MP0008874_decreased_physiological_sensi | 0.86320089 |
114 | MP0003941_abnormal_skin_development | 0.86115621 |
115 | MP0000750_abnormal_muscle_regeneration | 0.85876299 |
116 | MP0002877_abnormal_melanocyte_morpholog | 0.85750637 |
117 | MP0001873_stomach_inflammation | 0.83494125 |
118 | MP0002429_abnormal_blood_cell | 0.83110900 |
119 | MP0003866_abnormal_defecation | 0.82341605 |
120 | MP0002796_impaired_skin_barrier | 0.81566302 |
121 | MP0003300_gastrointestinal_ulcer | 0.81427190 |
122 | MP0002138_abnormal_hepatobiliary_system | 0.81039108 |
123 | MP0009763_increased_sensitivity_to | 0.80689823 |
124 | MP0003690_abnormal_glial_cell | 0.80561741 |
125 | MP0003795_abnormal_bone_structure | 0.80360165 |
126 | MP0000689_abnormal_spleen_morphology | 0.80206077 |
127 | MP0000703_abnormal_thymus_morphology | 0.75428657 |
128 | MP0003633_abnormal_nervous_system | 0.75297529 |
129 | MP0005647_abnormal_sex_gland | 0.75267217 |
130 | MP0004808_abnormal_hematopoietic_stem | 0.72902448 |
131 | MP0002332_abnormal_exercise_endurance | 0.71432333 |
132 | MP0005535_abnormal_body_temperature | 0.70071502 |
133 | MP0003634_abnormal_glial_cell | 0.66883400 |
134 | MP0005076_abnormal_cell_differentiation | 0.62192444 |
135 | MP0003045_fibrosis | 0.61999754 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of glycolipid metabolism (HP:0010969) | 6.16813183 |
2 | Abnormality of liposaccharide metabolism (HP:0010968) | 6.16813183 |
3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 6.16813183 |
4 | Epiphyseal dysplasia (HP:0002656) | 4.89633897 |
5 | Increased cerebral lipofuscin (HP:0011813) | 4.61464433 |
6 | Abnormality of macrophages (HP:0004311) | 4.36215245 |
7 | Irregular epiphyses (HP:0010582) | 4.22222291 |
8 | Dysostosis multiplex (HP:0000943) | 3.98793984 |
9 | Vacuolated lymphocytes (HP:0001922) | 3.95726607 |
10 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.93944243 |
11 | Neurofibrillary tangles (HP:0002185) | 3.65237041 |
12 | Cupped ribs (HP:0000887) | 3.56700518 |
13 | Systemic lupus erythematosus (HP:0002725) | 3.51861638 |
14 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.49999307 |
15 | Loss of speech (HP:0002371) | 3.49639671 |
16 | Reduced subcutaneous adipose tissue (HP:0003758) | 3.39419313 |
17 | Autoimmune thrombocytopenia (HP:0001973) | 3.31005176 |
18 | Mutism (HP:0002300) | 3.23185169 |
19 | Disinhibition (HP:0000734) | 3.08859129 |
20 | Interstitial pulmonary disease (HP:0006530) | 3.08650530 |
21 | Onycholysis (HP:0001806) | 3.03853818 |
22 | Acanthosis nigricans (HP:0000956) | 3.02651188 |
23 | Eczematoid dermatitis (HP:0000976) | 3.02544195 |
24 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.99605278 |
25 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.99605278 |
26 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.99605278 |
27 | Thrombocytosis (HP:0001894) | 2.97643771 |
28 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.93317369 |
29 | Myocardial infarction (HP:0001658) | 2.93160455 |
30 | Abnormality of binocular vision (HP:0011514) | 2.91454825 |
31 | Diplopia (HP:0000651) | 2.91454825 |
32 | Eosinophilia (HP:0001880) | 2.89695357 |
33 | Hypertriglyceridemia (HP:0002155) | 2.85863707 |
34 | Mucopolysacchariduria (HP:0008155) | 2.81887879 |
35 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.81887879 |
36 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.74674141 |
37 | Abnormal number of erythroid precursors (HP:0012131) | 2.67721495 |
38 | Small epiphyses (HP:0010585) | 2.66507633 |
39 | Myositis (HP:0100614) | 2.66256653 |
40 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.65355154 |
41 | Cerebral inclusion bodies (HP:0100314) | 2.65324264 |
42 | Abnormal tarsal ossification (HP:0008369) | 2.65117437 |
43 | Flat capital femoral epiphysis (HP:0003370) | 2.62475893 |
44 | Abnormality of the nasal mucosa (HP:0000433) | 2.58635230 |
45 | Amyloidosis (HP:0011034) | 2.56369431 |
46 | Axonal loss (HP:0003447) | 2.55645096 |
47 | Apathy (HP:0000741) | 2.54690826 |
48 | Abnormality of the axillary hair (HP:0100134) | 2.54232668 |
49 | Abnormality of secondary sexual hair (HP:0009888) | 2.54232668 |
50 | Diminished motivation (HP:0000745) | 2.54028898 |
51 | Vitreoretinal degeneration (HP:0000655) | 2.53427426 |
52 | Neuronal loss in central nervous system (HP:0002529) | 2.50112902 |
53 | Supranuclear gaze palsy (HP:0000605) | 2.46303383 |
54 | Recurrent abscess formation (HP:0002722) | 2.46225601 |
55 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.45239929 |
56 | Granulocytopenia (HP:0001913) | 2.44716653 |
57 | Absent epiphyses (HP:0010577) | 2.41420982 |
58 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 2.41420982 |
59 | Polycythemia (HP:0001901) | 2.40991291 |
60 | Vasculitis (HP:0002633) | 2.40967617 |
61 | Mesangial abnormality (HP:0001966) | 2.40933867 |
62 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.40539918 |
63 | Stomatitis (HP:0010280) | 2.40437922 |
64 | Abnormality of eosinophils (HP:0001879) | 2.38641582 |
65 | Increased CSF protein (HP:0002922) | 2.37605924 |
66 | Meningitis (HP:0001287) | 2.36075464 |
67 | Retrobulbar optic neuritis (HP:0100654) | 2.36051843 |
68 | Optic neuritis (HP:0100653) | 2.36051843 |
69 | Restrictive lung disease (HP:0002091) | 2.35212412 |
70 | Abnormality of the periventricular white matter (HP:0002518) | 2.33801584 |
71 | Oligomenorrhea (HP:0000876) | 2.31919231 |
72 | Cervical subluxation (HP:0003308) | 2.28276110 |
73 | Recurrent viral infections (HP:0004429) | 2.28065735 |
74 | B lymphocytopenia (HP:0010976) | 2.26141824 |
75 | Abnormality of B cell number (HP:0010975) | 2.26141824 |
76 | Chronic otitis media (HP:0000389) | 2.25866505 |
77 | Metaphyseal dysplasia (HP:0100255) | 2.25708296 |
78 | Abnormality of the prostate (HP:0008775) | 2.25179804 |
79 | T lymphocytopenia (HP:0005403) | 2.24101886 |
80 | Abnormality of T cell number (HP:0011839) | 2.23671356 |
81 | Cellulitis (HP:0100658) | 2.23638289 |
82 | Recurrent skin infections (HP:0001581) | 2.23039842 |
83 | Abnormality of the vertebral endplates (HP:0005106) | 2.22742676 |
84 | Reticulocytopenia (HP:0001896) | 2.22251117 |
85 | Multiple enchondromatosis (HP:0005701) | 2.21729142 |
86 | Nuclear cataract (HP:0100018) | 2.20082181 |
87 | Increased serum ferritin (HP:0003281) | 2.19959722 |
88 | Autoimmune hemolytic anemia (HP:0001890) | 2.19543627 |
89 | Nausea (HP:0002018) | 2.19392156 |
90 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.18702362 |
91 | Irregular vertebral endplates (HP:0003301) | 2.18650983 |
92 | Abnormality involving the epiphyses of the lower limbs (HP:0006500) | 2.18521537 |
93 | Abnormality of femoral epiphyses (HP:0006499) | 2.18521537 |
94 | Peripheral hypomyelination (HP:0007182) | 2.17403520 |
95 | Global brain atrophy (HP:0002283) | 2.17319001 |
96 | Asymmetric septal hypertrophy (HP:0001670) | 2.16867751 |
97 | Thyroid-stimulating hormone excess (HP:0002925) | 2.15461433 |
98 | Flat acetabular roof (HP:0003180) | 2.13786853 |
99 | Slow saccadic eye movements (HP:0000514) | 2.13779836 |
100 | Combined immunodeficiency (HP:0005387) | 2.13730910 |
101 | Gingivitis (HP:0000230) | 2.13591547 |
102 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.13403044 |
103 | Increased muscle lipid content (HP:0009058) | 2.12302177 |
104 | Prolonged bleeding time (HP:0003010) | 2.11042981 |
105 | Epistaxis (HP:0000421) | 2.10842483 |
106 | Adactyly (HP:0009776) | 2.09569431 |
107 | Metaphyseal cupping (HP:0003021) | 2.09550199 |
108 | Pulmonary infiltrates (HP:0002113) | 2.07809027 |
109 | Esophageal neoplasm (HP:0100751) | 2.07251654 |
110 | Neoplasm of head and neck (HP:0012288) | 2.07251654 |
111 | Ovoid vertebral bodies (HP:0003300) | 2.05625449 |
112 | Glossoptosis (HP:0000162) | 2.04889515 |
113 | Abnormal foot bone ossification (HP:0010675) | 2.04060229 |
114 | Abnormality of the femoral head (HP:0003368) | 2.02652415 |
115 | Polyneuropathy (HP:0001271) | 2.02440278 |
116 | Hypoplastic ischia (HP:0003175) | 2.01884105 |
117 | Recurrent bronchitis (HP:0002837) | 2.00026597 |
118 | Bone cyst (HP:0012062) | 1.99348954 |
119 | Pulmonary embolism (HP:0002204) | 1.96871249 |
120 | Tetraparesis (HP:0002273) | 1.95975610 |
121 | Respiratory distress (HP:0002098) | 1.94677447 |
122 | Genu varum (HP:0002970) | 1.94458122 |
123 | Abnormality of the epiphysis of the femoral head (HP:0010574) | 1.93981270 |
124 | Petechiae (HP:0000967) | 1.93773741 |
125 | Abnormality of the lumbar spine (HP:0100712) | 1.91979162 |
126 | Leukocytosis (HP:0001974) | 1.91832587 |
127 | Basal ganglia calcification (HP:0002135) | 1.91250987 |
128 | Obstructive lung disease (HP:0006536) | 1.91037171 |
129 | Chronic obstructive pulmonary disease (HP:0006510) | 1.91037171 |
130 | Recurrent bacterial skin infections (HP:0005406) | 1.90947494 |
131 | Progressive neurologic deterioration (HP:0002344) | 1.90610788 |
132 | Congenital, generalized hypertrichosis (HP:0004540) | 1.89132816 |
133 | Nasal polyposis (HP:0100582) | 1.89035930 |
134 | Recurrent fungal infections (HP:0002841) | 1.88869628 |
135 | Hematochezia (HP:0002573) | 1.88514649 |
136 | Chest pain (HP:0100749) | 1.88174267 |
137 | Pulmonary fibrosis (HP:0002206) | 1.88118202 |
138 | Abnormality of iron homeostasis (HP:0011031) | 1.87072579 |
139 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.86708479 |
140 | Paralysis (HP:0003470) | 1.86547692 |
141 | Increased IgE level (HP:0003212) | 1.86479707 |
142 | Pustule (HP:0200039) | 1.86423974 |
143 | Keratoconjunctivitis sicca (HP:0001097) | 1.86318682 |
144 | Spontaneous hematomas (HP:0007420) | 1.85509706 |
145 | Orchitis (HP:0100796) | 1.85425197 |
146 | Severe combined immunodeficiency (HP:0004430) | 1.83893155 |
147 | Dementia (HP:0000726) | 1.83870906 |
148 | Acrocyanosis (HP:0001063) | 1.83649336 |
149 | Metaphyseal irregularity (HP:0003025) | 1.82875144 |
150 | Urticaria (HP:0001025) | 1.80991666 |
151 | Conjunctival telangiectasia (HP:0000524) | 1.80969316 |
152 | Skin ulcer (HP:0200042) | 1.80342181 |
153 | Stillbirth (HP:0003826) | 1.79639476 |
154 | Abnormal cartilage morphology (HP:0002763) | 1.78586553 |
155 | Polygenic inheritance (HP:0010982) | 1.78409836 |
156 | Vertigo (HP:0002321) | 1.78121335 |
157 | Mediastinal lymphadenopathy (HP:0100721) | 1.77445351 |
158 | Hemoptysis (HP:0002105) | 1.77138332 |
159 | Hepatosplenomegaly (HP:0001433) | 1.77091204 |
160 | Glomerulonephritis (HP:0000099) | 1.76294788 |
161 | Pulmonary artery stenosis (HP:0004415) | 1.74346185 |
162 | Abnormality of T cells (HP:0002843) | 1.73714924 |
163 | Osteoarthritis (HP:0002758) | 1.72792304 |
164 | Lumbar hyperlordosis (HP:0002938) | 1.72348255 |
165 | Joint stiffness (HP:0001387) | 1.71553298 |
166 | Short femoral neck (HP:0100864) | 1.70758158 |
167 | Purpura (HP:0000979) | 1.70203995 |
168 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.69514120 |
169 | Hypergammaglobulinemia (HP:0010702) | 1.68987372 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TIE1 | 4.27625218 |
2 | KDR | 3.15319316 |
3 | MAP3K3 | 3.09500853 |
4 | PRPF4B | 3.05869204 |
5 | RIPK4 | 2.95555049 |
6 | TGFBR2 | 2.56138389 |
7 | MST4 | 2.51517807 |
8 | MAP4K1 | 2.34312636 |
9 | ERN1 | 2.27513925 |
10 | TEC | 2.23349674 |
11 | MAP3K13 | 2.15717627 |
12 | NME2 | 2.10528213 |
13 | PIM2 | 2.06269053 |
14 | TXK | 2.06070542 |
15 | PDK2 | 2.02474036 |
16 | STK10 | 2.00240971 |
17 | CAMK1D | 1.86457161 |
18 | MAP2K3 | 1.85401674 |
19 | IRAK3 | 1.75906417 |
20 | LMTK2 | 1.73468841 |
21 | TRIB3 | 1.72492543 |
22 | STK24 | 1.72154106 |
23 | ZAP70 | 1.65309285 |
24 | TAOK3 | 1.62595234 |
25 | TRPM7 | 1.60719242 |
26 | TBK1 | 1.59111429 |
27 | IKBKE | 1.56507051 |
28 | BMPR2 | 1.55700262 |
29 | MAP3K14 | 1.54421807 |
30 | IRAK4 | 1.53730081 |
31 | MST1R | 1.52293432 |
32 | LRRK2 | 1.51036265 |
33 | MOS | 1.32997628 |
34 | VRK1 | 1.32652298 |
35 | MAPK12 | 1.29400216 |
36 | MAPKAPK3 | 1.27097286 |
37 | MYLK | 1.26623677 |
38 | MAP3K11 | 1.24873776 |
39 | JAK3 | 1.22807253 |
40 | DAPK2 | 1.20079449 |
41 | MAP3K1 | 1.19487101 |
42 | TAOK1 | 1.18309218 |
43 | MAPK15 | 1.17334773 |
44 | ILK | 1.16136905 |
45 | PHKG2 | 1.15633011 |
46 | PHKG1 | 1.15633011 |
47 | MATK | 1.11815658 |
48 | SIK1 | 1.11792027 |
49 | NLK | 1.10170617 |
50 | FGR | 1.10129828 |
51 | PIM1 | 1.09783250 |
52 | PRKG2 | 1.09156319 |
53 | BLK | 1.09145657 |
54 | EIF2AK3 | 1.09053708 |
55 | ITK | 1.07252450 |
56 | EIF2AK2 | 1.06972907 |
57 | DDR2 | 1.04625401 |
58 | RIPK1 | 0.98150678 |
59 | TNK2 | 0.97447258 |
60 | CAMKK1 | 0.95728256 |
61 | MAPK4 | 0.95232140 |
62 | ARAF | 0.94996280 |
63 | BTK | 0.91554226 |
64 | TAOK2 | 0.89955973 |
65 | TYRO3 | 0.89667044 |
66 | MARK3 | 0.89167827 |
67 | IRAK2 | 0.88908650 |
68 | IKBKB | 0.87738212 |
69 | CDC42BPA | 0.86141891 |
70 | BCKDK | 0.85902427 |
71 | TYK2 | 0.84369047 |
72 | PBK | 0.83807748 |
73 | PDK4 | 0.83148790 |
74 | PDK3 | 0.83148790 |
75 | TGFBR1 | 0.81964484 |
76 | FGFR3 | 0.81561939 |
77 | MARK2 | 0.80722416 |
78 | CSK | 0.80092149 |
79 | TESK1 | 0.79791771 |
80 | GRK1 | 0.79412055 |
81 | ERBB3 | 0.78161904 |
82 | TESK2 | 0.76398235 |
83 | SYK | 0.76302231 |
84 | HIPK2 | 0.76005585 |
85 | CAMK1G | 0.73080365 |
86 | PDK1 | 0.72877118 |
87 | LCK | 0.72778986 |
88 | CSF1R | 0.71778268 |
89 | NME1 | 0.71187155 |
90 | PDPK1 | 0.69623994 |
91 | MAPK7 | 0.69475849 |
92 | GRK6 | 0.68391679 |
93 | ABL2 | 0.66937517 |
94 | CDK9 | 0.65381579 |
95 | SIK3 | 0.65261627 |
96 | SGK3 | 0.63906028 |
97 | KIT | 0.62921001 |
98 | JAK1 | 0.62917503 |
99 | CHUK | 0.62805143 |
100 | CAMKK2 | 0.62703129 |
101 | IGF1R | 0.61721328 |
102 | RPS6KL1 | 0.61692497 |
103 | RPS6KC1 | 0.61692497 |
104 | EPHB1 | 0.60764151 |
105 | SGK2 | 0.60628507 |
106 | MAP2K2 | 0.58016530 |
107 | KSR2 | 0.56640425 |
108 | CLK1 | 0.52357284 |
109 | ADRBK2 | 0.52087388 |
110 | GSK3A | 0.51813585 |
111 | PRKAA2 | 0.51528610 |
112 | GRK7 | 0.51408047 |
113 | JAK2 | 0.51335650 |
114 | MUSK | 0.51247450 |
115 | RPS6KA6 | 0.51077538 |
116 | TTN | 0.50953546 |
117 | HCK | 0.50698441 |
118 | MAP3K5 | 0.49201011 |
119 | GRK5 | 0.48599669 |
120 | BMX | 0.47239100 |
121 | PDGFRB | 0.46829132 |
122 | EPHA3 | 0.46055610 |
123 | RPS6KA4 | 0.45760076 |
124 | MAP2K6 | 0.45710376 |
125 | CAMK4 | 0.45546722 |
126 | NEK9 | 0.45541789 |
127 | CASK | 0.44712499 |
128 | RPS6KA2 | 0.42577801 |
129 | CDK6 | 0.41634897 |
130 | TSSK6 | 0.41323193 |
131 | FES | 0.41076730 |
132 | ABL1 | 0.40977840 |
133 | FYN | 0.40752507 |
134 | PRKCQ | 0.40554117 |
135 | LYN | 0.40371201 |
136 | PIK3CA | 0.40256082 |
137 | PIK3CG | 0.40040386 |
138 | SGK223 | 0.39889464 |
139 | SGK494 | 0.39889464 |
140 | MAP3K12 | 0.39177692 |
141 | IRAK1 | 0.36390491 |
142 | MAP3K8 | 0.34621897 |
143 | MAPK3 | 0.30615025 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Ribosome_Homo sapiens_hsa03010 | 2.96017163 |
2 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.72915679 |
3 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.51365171 |
4 | Malaria_Homo sapiens_hsa05144 | 2.43212129 |
5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.21789085 |
6 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.19020521 |
7 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 2.15641623 |
8 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.06189618 |
9 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.98878304 |
10 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.94966938 |
11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.83759222 |
12 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.83128989 |
13 | Leishmaniasis_Homo sapiens_hsa05140 | 1.82182822 |
14 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.78145224 |
15 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.77920369 |
16 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.70812457 |
17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.67664390 |
18 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.65419127 |
19 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.64947997 |
20 | Other glycan degradation_Homo sapiens_hsa00511 | 1.60736076 |
21 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.56808927 |
22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.56278398 |
23 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.56016166 |
24 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.52081101 |
25 | Protein export_Homo sapiens_hsa03060 | 1.48750298 |
26 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.45880894 |
27 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.45743672 |
28 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.40763418 |
29 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.39392635 |
30 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.38447277 |
31 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.36275804 |
32 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.33991879 |
33 | Measles_Homo sapiens_hsa05162 | 1.30606229 |
34 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.27560758 |
35 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.25186438 |
36 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.22525336 |
37 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.21723205 |
38 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.21347686 |
39 | Asthma_Homo sapiens_hsa05310 | 1.20304960 |
40 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.17701295 |
41 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.17059417 |
42 | Prion diseases_Homo sapiens_hsa05020 | 1.15401892 |
43 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.15203051 |
44 | DNA replication_Homo sapiens_hsa03030 | 1.14177039 |
45 | Legionellosis_Homo sapiens_hsa05134 | 1.11321841 |
46 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.09037331 |
47 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.08612758 |
48 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.00710314 |
49 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.98083748 |
50 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.95746904 |
51 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.95458292 |
52 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.95420051 |
53 | HTLV-I infection_Homo sapiens_hsa05166 | 0.95095340 |
54 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.94990115 |
55 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.93150632 |
56 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.92885669 |
57 | Viral myocarditis_Homo sapiens_hsa05416 | 0.91765554 |
58 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.91386401 |
59 | Apoptosis_Homo sapiens_hsa04210 | 0.90372133 |
60 | Lysosome_Homo sapiens_hsa04142 | 0.89804459 |
61 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.89428822 |
62 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.89247859 |
63 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.89043008 |
64 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.87946335 |
65 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.86813259 |
66 | Allograft rejection_Homo sapiens_hsa05330 | 0.85842097 |
67 | Focal adhesion_Homo sapiens_hsa04510 | 0.84857460 |
68 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.83842856 |
69 | Thyroid cancer_Homo sapiens_hsa05216 | 0.83785136 |
70 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.83784427 |
71 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.82396762 |
72 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.79641964 |
73 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.78759232 |
74 | Influenza A_Homo sapiens_hsa05164 | 0.78403367 |
75 | Parkinsons disease_Homo sapiens_hsa05012 | 0.78120064 |
76 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.77874646 |
77 | Shigellosis_Homo sapiens_hsa05131 | 0.77504690 |
78 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.76617770 |
79 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.76554664 |
80 | Hepatitis C_Homo sapiens_hsa05160 | 0.75363858 |
81 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.75241494 |
82 | Pertussis_Homo sapiens_hsa05133 | 0.74942328 |
83 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.74783184 |
84 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.74210999 |
85 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.72614473 |
86 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.69894615 |
87 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.68509994 |
88 | Platelet activation_Homo sapiens_hsa04611 | 0.67842062 |
89 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.67438036 |
90 | Carbon metabolism_Homo sapiens_hsa01200 | 0.67169796 |
91 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.66708535 |
92 | Tuberculosis_Homo sapiens_hsa05152 | 0.66528737 |
93 | Phagosome_Homo sapiens_hsa04145 | 0.65455761 |
94 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.64897900 |
95 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.64422625 |
96 | Endocytosis_Homo sapiens_hsa04144 | 0.64148441 |
97 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.64121529 |
98 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.63102938 |
99 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.62939547 |
100 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.62536909 |
101 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.62130825 |
102 | Insulin resistance_Homo sapiens_hsa04931 | 0.61905134 |
103 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.60406699 |
104 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.59490744 |
105 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.58316829 |
106 | Sulfur relay system_Homo sapiens_hsa04122 | 0.57258533 |
107 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.56166949 |
108 | Base excision repair_Homo sapiens_hsa03410 | 0.55688760 |
109 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.55214973 |
110 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.53434288 |
111 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.53324814 |
112 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.52376813 |
113 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.52134326 |
114 | Hepatitis B_Homo sapiens_hsa05161 | 0.51596457 |
115 | Circadian rhythm_Homo sapiens_hsa04710 | 0.50780639 |
116 | Amoebiasis_Homo sapiens_hsa05146 | 0.49789848 |
117 | Bladder cancer_Homo sapiens_hsa05219 | 0.49227321 |
118 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.49002159 |
119 | Long-term potentiation_Homo sapiens_hsa04720 | 0.47733535 |
120 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.47559854 |
121 | Salmonella infection_Homo sapiens_hsa05132 | 0.47296365 |
122 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.46355109 |
123 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.46059834 |
124 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.45809211 |
125 | Renin secretion_Homo sapiens_hsa04924 | 0.45663010 |
126 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.45643668 |
127 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.45605097 |
128 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.44751070 |
129 | Galactose metabolism_Homo sapiens_hsa00052 | 0.44584470 |
130 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.43018099 |
131 | Huntingtons disease_Homo sapiens_hsa05016 | 0.42730721 |
132 | Proteasome_Homo sapiens_hsa03050 | 0.42336952 |
133 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.42311279 |
134 | Alzheimers disease_Homo sapiens_hsa05010 | 0.42093098 |
135 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.41705958 |
136 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.41469087 |
137 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.40998834 |
138 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.40716022 |
139 | Mineral absorption_Homo sapiens_hsa04978 | 0.40371947 |
140 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.40053763 |
141 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.39619820 |
142 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.39303955 |
143 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.36880853 |
144 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.36823292 |